Literature DB >> 23733753

Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.

Timothy J Judson1, Antonia V Bennett, Lauren J Rogak, Laura Sit, Allison Barz, Mark G Kris, Clifford A Hudis, Howard I Scher, Paul Sabattini, Deborah Schrag, Ethan Basch.   

Abstract

PURPOSE: Patient-reported outcomes are increasingly used in routine outpatient cancer care to guide clinical decisions and enhance communication. Prior evidence suggests good patient compliance with reporting at scheduled clinic visits, but there is limited evidence about compliance with long-term longitudinal reporting between visits. PATIENTS AND METHODS: Patients receiving chemotherapy for lung, gynecologic, genitourinary, or breast cancer at a tertiary cancer center, with access to a home computer and prior e-mail experience, were asked to self-report seven symptomatic toxicities via the Web between visits. E-mail reminders were sent to participants weekly; patient-reported high-grade toxicities triggered e-mail alerts to nurses; printed reports were provided to oncologists at visits. A priori threshold criteria were set to determine if this data collection approach merited further development based on monthly (≥ 75% participants reporting at least once per month on average) and weekly compliance rates (60% at least once per week).
RESULTS: Between September 2006 and November 2010, 286 patients were enrolled (64% were women; 88% were white; median age, 58 years). Mean follow-up was 34 weeks (range, 2 to 214). On average, monthly compliance was 83%, and weekly compliance was 62%, without attrition until the month before death. Greater compliance was associated with older age and higher education but not with performance status. Compliance was greatest during the initial 12 weeks. Symptomatic illness and technical problems were rarely barriers to compliance.
CONCLUSION: Monthly compliance with home Web reporting was high, but weekly compliance was lower, warranting strategies to enhance compliance in routine care settings.

Entities:  

Mesh:

Year:  2013        PMID: 23733753      PMCID: PMC3699724          DOI: 10.1200/JCO.2012.47.6804

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  32 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Evaluation of the relationship between individual well-being and future health care utilization and cost.

Authors:  Patricia L Harrison; James E Pope; Carter R Coberley; Elizabeth Y Rula
Journal:  Popul Health Manag       Date:  2012-02-22       Impact factor: 2.459

3.  Patient-reported medication symptoms in primary care.

Authors:  Saul N Weingart; Tejal K Gandhi; Andrew C Seger; Diane L Seger; Joshua Borus; Elisabeth Burdick; Lucian L Leape; David W Bates
Journal:  Arch Intern Med       Date:  2005-01-24

4.  Patient online self-reporting of toxicity symptoms during chemotherapy.

Authors:  Ethan Basch; David Artz; Dorothy Dulko; Kevin Scher; Paul Sabbatini; Martee Hensley; Nandita Mitra; John Speakman; Mary McCabe; Deborah Schrag
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

5.  Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

Authors:  G Buccheri; D Ferrigno; M Tamburini
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

6.  Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities.

Authors:  Ethan Basch; David Artz; Alexia Iasonos; John Speakman; Kevin Shannon; Kai Lin; Charmaine Pun; Henry Yong; Paul Fearn; Allison Barz; Howard I Scher; Mary McCabe; Deborah Schrag
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

7.  Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.

Authors:  Ethan Basch; Alexia Iasonos; Tiffani McDonough; Allison Barz; Ann Culkin; Mark G Kris; Howard I Scher; Deborah Schrag
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

8.  Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993).

Authors:  F J Fowler; M J Barry; G Lu-Yao; A Roman; J Wasson; J E Wennberg
Journal:  Urology       Date:  1993-12       Impact factor: 2.649

9.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

View more
  52 in total

Review 1.  The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review.

Authors:  Thomas M Atkinson; Charissa F Andreotti; Kailey E Roberts; Rebecca M Saracino; Marisol Hernandez; Ethan Basch
Journal:  Support Care Cancer       Date:  2015-08-28       Impact factor: 3.603

2.  Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Amylou C Dueck; Tito R Mendoza; Sandra A Mitchell; Bryce B Reeve; Kathleen M Castro; Lauren J Rogak; Thomas M Atkinson; Antonia V Bennett; Andrea M Denicoff; Ann M O'Mara; Yuelin Li; Steven B Clauser; Donna M Bryant; James D Bearden; Theresa A Gillis; Jay K Harness; Robert D Siegel; Diane B Paul; Charles S Cleeland; Deborah Schrag; Jeff A Sloan; Amy P Abernethy; Deborah W Bruner; Lori M Minasian; Ethan Basch
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

Review 3.  The increasing value of eHealth in the delivery of patient-centred cancer care.

Authors:  Frank J Penedo; Laura B Oswald; Joshua P Kronenfeld; Sofia F Garcia; David Cella; Betina Yanez
Journal:  Lancet Oncol       Date:  2020-05       Impact factor: 41.316

4.  Feasibility of Conducting a Palliative Care Randomized Controlled Trial in Children With Advanced Cancer: Assessment of the PediQUEST Study.

Authors:  Veronica Dussel; Liliana Orellana; Natalie Soto; Kun Chen; Christina Ullrich; Tammy I Kang; Jeffrey R Geyer; Chris Feudtner; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2015-01-30       Impact factor: 3.612

5.  How to optimize participant retention and complete follow-up in surgical research.

Authors:  Manrajr Kaur; Sheila Sprague; Teegan Ignacy; Achilles Thoma; Mohit Bhandari; Forough Farrokhyar
Journal:  Can J Surg       Date:  2014-12       Impact factor: 2.089

6.  The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.

Authors:  Chiara Baratelli; Carmela Giovanna Cleopatra Turco; Gaetano Lacidogna; Elisa Sperti; Francesca Vignani; Donatella Marino; Clizia Zichi; Emmanuele De Luca; Marco Audisio; Daniela Ballaminut; Annalisa Bellezza; Paola Chiotto; Giovanna Ciriolo; Rossella Comite; Fulvia Codegone; Santina Florio; Luisa Fusco; Laura Polimeno; Donatella Pozzi; Eliana Zilio; Sabrina Terzolo; Massimo Di Maio
Journal:  Support Care Cancer       Date:  2019-04-04       Impact factor: 3.603

7.  An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients.

Authors:  Richard Baird; Ian Banks; David Cameron; John Chester; Helena Earl; Mark Flannagan; Adam Januszewski; Richard Kennedy; Sarah Payne; Emlyn Samuel; Hannah Taylor; Roshan Agarwal; Samreen Ahmed; Caroline Archer; Ruth Board; Judith Carser; Ellen Copson; David Cunningham; Rob Coleman; Adam Dangoor; Graham Dark; Diana Eccles; Chris Gallagher; Adam Glaser; Richard Griffiths; Geoff Hall; Marcia Hall; Danielle Harari; Michael Hawkins; Mark Hill; Peter Johnson; Alison Jones; Tania Kalsi; Eleni Karapanagiotou; Zoe Kemp; Janine Mansi; Ernie Marshall; Alex Mitchell; Maung Moe; Caroline Michie; Richard Neal; Tom Newsom-Davis; Alison Norton; Richard Osborne; Gargi Patel; John Radford; Alistair Ring; Emily Shaw; Rod Skinner; Dan Stark; Sam Turnbull; Galina Velikova; Jeff White; Alison Young; Johnathan Joffe; Peter Selby
Journal:  Ecancermedicalscience       Date:  2016-01-05

8.  Overview of Patient-Facing Systems in Patient-Reported Outcomes Collection: Focus and Design in Cancer Care.

Authors:  Roxanne E Jensen; Scott P Gummerson; Arlene E Chung
Journal:  J Oncol Pract       Date:  2016-10       Impact factor: 3.840

9.  Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.

Authors:  Markus Wallwiener; Felix Heindl; Sara Y Brucker; Florin-Andrei Taran; Andreas Hartkopf; Friedrich Overkamp; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Michael P Lux; Claudia Rauh; Simon Blum; Naiba Nabieva; Tobias F Brodkorb; Cornelia Faschingbauer; Hanna Langemann; Carla Schulmeyer; Bernhard Volz; Matthias Rübner; Diana Lüftner; Volkmar Müller; Erik Belleville; Wolfgang Janni; Tanja N Fehm; Diethelm Wallwiener; Thomas Ganslandt; Matthias W Beckmann; Andreas Schneeweiss; Peter A Fasching; Paul Gass
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

10.  Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.

Authors:  Stefan Stefanovic; Markus Wallwiener; Uros Karic; Christoph Domschke; Luka Katic; Florin-Andrei Taran; Aleksandra Pesic; Andreas Hartkopf; Peyman Hadji; Martin Teufel; Florian Schuetz; Christof Sohn; Peter Fasching; Andreas Schneeweiss; Sara Brucker
Journal:  Support Care Cancer       Date:  2016-10-17       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.